NovaBay Pharmaceuticals Reports Third Quarter Financial Results – msnbc.com

EMERYVILLE, Calif., Nov. 7, 2011 (GLOBE NEWSWIRE) — NovaBay ® Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide® compounds for the local non-systemic …